{
    "SPADE_N_15580": {
        "Sequence Information": {
            "Peptide Name": "Axinastatin 5",
            "Sequence": "ILPPYVPL",
            "Sequence Length": 8,
            "Biological Activity": [
                "Anticancer"
            ],
            "Binding Target": "1. Mitochondrial membrane",
            "Source": "1. Axinella cf. carteri (Stylissa carteri)\n2. Phakellia fusca",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "Isolation and structure of axinastatin 5 from a republic of comoros marine sponge",
                    "Pubmed ID": "",
                    "Reference": "Bioorg Med Chem Lett. 1994;4:2935-2940",
                    "Author": "Pettit GR, Gao F, Schmidt JM, Chapuis JC, Cerny RL",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/"
                },
                {
                    "Title": "Antineoplastic agents. 536. New sources of naturally occurring cancer cell growth inhibitors from marine organisms, terrestrial plants, and microorganisms",
                    "Pubmed ID": "18327911",
                    "Reference": "J Nat Prod. 2008;71:438-444",
                    "Author": "Pettit GR, Hogan F, Xu JP, Tan R, Nogawa T, Cichacz Z, Pettit RK, Du J, Ye QH, Cragg GM, Herald CL, Hoard MS, Goswami A, Searcy J, Tackett L, Doubek DL, Williams L, Hooper JN, Schmidt JM, Chapuis JC, Tackett DN, Craciunescu F",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/18327911"
                }
            ],
            "Mass": 911.14,
            "PI": 5.52,
            "Net Charge": 0,
            "Hydrophobicity": 1.27,
            "Frequent Amino Acids": "PLI",
            "Absent Amino Acids": "ACDEFGHKMNOQRSTUW",
            "Basic Residues": 0,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 4,
            "Polar Residues": 4,
            "Positive Residues": 0,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_N_15580",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06870",
                    "Similarity": 1.0,
                    "Sequence": "FILP"
                },
                {
                    "SPADE_ID": "SPADE_UN_11185",
                    "Similarity": 1.0,
                    "Sequence": "LPP"
                },
                {
                    "SPADE_ID": "SPADE_N_02593",
                    "Similarity": 1.0,
                    "Sequence": "YVPLPNVPQPGRRPFPTFPGQGPFNPKIKWPQGY"
                }
            ],
            "Hemolytic Activity": "",
            "Target Organism": "Human epithelial carcinoma OVCAR-3(IC50=0.3µg/ml),Human glioblastoma SF-295(IC50=1.6µg/ml),Human renal carcinoma A498(IC50=2.3µg/ml),Human skin melanoma SK-MEL-5(IC50=0.5µg/ml),Mouse lymphoma cells P388(IC50=1.9µg/ml),Human lung carcinoma NCI-H460(IC50=0.82µg/ml),Human colon adenocarcinoma KM20L2(IC50=0.28µg/ml),Human prostate cancer DU145(IC50=0.87µg/ml),Human pancreatic adenocarcinoma BxPC-3(IC50=0.68µg/ml),Human breast adenocarcinoma MCF-7(IC50=1.4µg/ml),Human Astrocytoma SF-268(IC50=1.8µg/ml)"
        }
    }
}